Intracellular expression of cytokines in peripheral blood from patients with atherosclerosis before and after carotid endarterectomy

Atherosclerosis

Volumn 191, Issue 2, 2007, Pages 340-347

  Profumo, Elisabetta ^a   Esposito, Claudia ^a   Buttari, Brigitta ^a   Tosti, Maria Elena ^a   Ortona, Elena ^a   Margutti, Paola ^a   Siracusano, Alessandra ^a   Sposato, Angela ^b   Costanzo, Alessandro ^b   Capoano, Raffaele ^b   Salvati, Bruno ^b   Riganò, Rachele ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Atherosclerosis; Blood cells; Carotid arteries; Follow up studies; Interleukins

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; ATHEROSCLEROSIS; BLOOD; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; STENOSIS; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CYTOKINES; DISEASE PROGRESSION; ENDARTERECTOMY, CAROTID; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; INTERFERON TYPE II; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 33947156314     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.03.030     Document Type: Article

References (35)

1. Hansson G.K. Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease. New Engl J Med 352 (2005) 1685-1695
2. Young J.L., Libby P., and Schonbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 88 (2002) 554-567
3. Ozer K., and Cilingiroglu M. Vulnerable plaque: definition, detection, treatment, and future implications. Curr Atheroscler Rep 7 (2005) 121-126
4. Biasucci L.M., Vitelli A., Liuzzo G., et al. Elevated levels of interleukin-6 in unstable angina. Circulation 94 (1996) 874-877
5. Treska V., Topolcan O., and Pecen L. Cytokines as plasma markers of abdominal aortic aneurysm. Clin Chem Lab Med 38 (2000) 1161-1164
6. Heeschen C., Dimmeler S., Hamm C.W., et al. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107 (2003) 2109-2114
7. Lee S.H., Jeong M.H., Bae H.R., et al. Circulating levels of interleukin-8 and vascular endothelial growth factor in patients with carotid stenosis. J Korean Med Sci 16 (2001) 198-203
8. Fernandes J.L., Mamoni R.L., Orford J.L., et al. Increased Th1 activity in patients with coronary artery disease. Cytokine 26 (2004) 131-137
9. Profumo E., Siracusano A., Ortona E., et al. Cytokine expression in circulating T lymphocytes from patients undergoing carotid endarterectomy. J Cardiovasc Surg 44 (2003) 237-242
10. Leu H.B., Chen J.W., Wu T.C., et al. Effects of fluvastatin, an HMG-CoA reductase inhibitor, on serum levels of interleukin-18 and matrix metalloproteinase-9 in patients with hypercholesterolemia. Clin Cardiol 28 (2005) 423-428
11. Tikiz C., Utuk O., Pirildar T., et al. Effects of angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with long term rheumatoid arthritis. J Rheumatol 32 (2005) 2095-2101
12. Kulbertus H. Aspirin: recent advances in cardiovascular prevention. Rev Med Liege 59 (2004) 695-703
13. Frostegard J., Ulfgren A.K., Nyberg P., et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145 (1999) 33-43
14. Uyemura K., Demer L.L., Castle S.C., et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 97 (1996) 2130-2138
15. Mallat Z., Heymes C., Ohan J., et al. Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 19 (1999) 611-616
16. Young Y.L., Libby P., and Schonbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 88 (2002) 554-567
17. Davenport P., and Tipping P.G. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 163 (2003) 1117-1125
18. Gupta S., Pablo A.M., Jiang X., et al. IFN-gamma potentiates atherosclerosis in apoE knock-out mice. J Clin Invest 99 (1997) 2752-2761
19. Whitman S.C., Ravisankar P., and Daugherty A. IFN-gamma deficiency exerts gender specific effects on atherogenesis in apolipoprotein E-/-mice. J Interferon Cytokine Res 22 (2002) 661-670
20. King V.L., Szilvassy S.J., and Daugherty A. Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/-mice. Arterioscler Thromb Vasc Biol 22 (2002) 456-461
21. Zhou X., Paulsson G., Stemme S., and Hansson G.K. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest 101 (1998) 1717-1725
22. Iademarco M.F., Barks J.L., and Dean D.C. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells. J Clin Invest 95 (1995) 264-271
23. Barks J.L., McQuillan J.J., and Iademarco M.F. TNF-alpha and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells. J Immunol 159 (1997) 4532-4538
24. Huang J.T., Welch J.S., Ricote M., et al. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature 400 (1999) 378-382
25. Conrad D.J., Kuhn H., Mulkins M., Highland E., and Sigal E. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc Natl Acad Sci USA 89 (1992) 217-221
26. George Y., Shoenfeld Y., Gilburd B., et al. Requisite role for interleukin-4 in the acceleration of fatty streaks induced by Heat Shock Protein 65 or Mycobacterium tuberculosis. Circ Res 86 (2000) 1203-1210
27. Zimmerman M.A., Reznikov L.L., Raeburn C.D., and Selzman C.H. Interleukin-10 attenuates the response to vascular injury. J Surg Res 121 (2004) 206-213
28. Smith D.A., Irving S.D., Sheldon J., Cole D., and Kaski J.C. Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 104 (2001) 746-749
29. Pala P., Hussell T., and Openshaw P.J. Flow cytometric measurement of intracellular cytokines. J Immunol Methods 243 (2000) 107-124
30. Biasucci L.M., Liuzzo G., Fantuzzi G., et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 99 (1999) 2079-2084
31. Ridker P.M., Rifai N., Pfeffer M., et al. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101 (2000) 2149-2153
32. Mazzone A., De Servi S., Vezzoli M., et al. Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis 145 (1999) 369-374
33. Simon A.D., Yazdani S., Wang W., Schwartz A., and Rabbani L.E. Circulating levels of IL-1β, a prothrombotic cytokine, are elevated in unstable angina versus stable angina. J Thromb Thrombolysis 9 (2000) 217-222
34. Rus H., and Niculescu F. Inflammatory response in unstable angina. Circulation 100 (1999) e98
35. Fumeaux T., Dufour J., Stern S., and Pugin J. Immune monitoring of patients with septic shock by measurement of intraleukocyte cytokines. Intensive Care Med 30 (2004) 2028-2037